Long Term Responses to Fludarabine and Rituximab in Waldenstrom's Macroglobulinemia

被引：0
|
作者：
Treon, Steven
Branagan, Andrew
Ioakimidis, Leukothea [1 ]
Soumerai, Jacob
Patterson, Christopher
Wasi, Parveen [2 ]
Emmanouilides, Christos [3 ]
Frankel, Stanley R. [4 ]
Lister, Andrew [5 ]
Morel, Pierre [6 ]
Matous, Jeffrey [7 ]
Gregory, Stephanie A. [8 ]
Kimby, Eva K. [9 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] Interbalkan Hosp, Pylaia, Greece
[4] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[5] Ctr Med Oncol, London, England
[6] Serv Hematol Clin, Lens, France
[7] Rocky Mt Canc Ctr, Denver, CO USA
[8] Rush Univ, Chicago, IL 60612 USA
[9] Karolinska Inst, Hematol Ctr, Stockholm, Sweden
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1051 / 1051
页数：1
相关论文
共 50 条
  • [1] Long-term outcomes to fludarabine and rituximab in Waldenstrom macroglobulinemia
    Treon, Steven P.
    Branagan, Andrew R.
    Ioakimidis, Leukothea
    Soumerai, Jacob D.
    Patterson, Christopher J.
    Turnbull, Barry
    Wasi, Parveen
    Emmanouilides, Christos
    Frankel, Stanley R.
    Lister, Andrew
    Morel, Pierre
    Matous, Jeffrey
    Gregory, Stephanie A.
    Kimby, Eva
    [J]. BLOOD, 2009, 113 (16) : 3673 - 3678
  • [2] A point on the long term effect of the fludarabine and rituximab association in the Waldenstrom Macroglobulinemia
    Balkaran, Sandy
    Leleu, Xavier
    [J]. HEMATOLOGIE, 2009, 15 (03): : 178 - 179
  • [3] Long-term responses to thalidomide and rituximab in Waldenstrom's macroglobulinemia
    Soumerai, J. D.
    Branagan, A. R.
    Patterson, C. J.
    Hunter, Z. R.
    Treon, S. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenstrom's Macroglobulinemia
    Tedeschi, Alessandra
    Ricci, Francesca
    Goldaniga, Maria Cecilia
    Benevolo, Giulia
    Varettoni, Marzia
    Motta, Marina
    Pioltelli, Pietro
    Gini, Guido
    Barate', Claudia
    Luraschi, Annamaria
    Vismara, Eleonora
    Frustaci, Anna Maria
    Nichelatti, Michele
    Vitolo, Umberto
    Baldini, Luca
    Morra, Enrica
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02): : 231 - 234
  • [5] Combination therapy with rituximab and fludarabine in Waldenstrom's Macroglobulinemia.
    Treon, SP
    Branagan, A
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Lister, A
    Morel, P
    Matous, J
    Enschede, SH
    Kimby, E
    [J]. BLOOD, 2004, 104 (11) : 215A - 215A
  • [6] Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia
    Souchet, Laetitia
    Levy, Vincent
    Ouzegdouh, Maya
    Tamburini, Jerome
    Delmer, Alain
    Dupuis, Jehan
    Le Gouill, Steven
    Pegourie-Bandelier, Brigitte
    Tournilhac, Olivier
    Boubaya, Marouanne
    Vargaftig, Jacques
    Choquet, Sylvain
    Leblond, Veronique
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (08) : 782 - 786
  • [7] Fludarabine in Waldenstrom's macroglobulinemia
    Leblond, V
    Choquet, S
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (02) : 239 - 242
  • [8] Fludarabine in Waldenstrom's macroglobulinemia
    Souchet-Compain, Laetitia
    Stephanie Nguyen
    Choquet, Sylvain
    Leblond, Veronique
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (03) : 229 - 237
  • [9] Long Term Toxicity and Follow-up of Waldenstrom's Macroglobulinemia Patients after Salvage Treatment with Fludarabine Cyclophosphamide Rituximab or Bendamustine and Rituximab
    Tedeschi, Alessandra
    Picardi, Paola
    Goldaniga, Maria Cecilia
    Casaluci, Gloria Margiotta
    Benevolo, Giulia
    Ferrero, Simone
    Varettoni, Marzia
    Barate, Claudia
    Gini, Guido
    Visco, Carlo
    Motta, Marina
    Petrizzi, Valeria Belsito
    Zaja, Francesco
    Ravelli, Erica
    Gentile, Massimo
    Frustaci, Anna Maria
    Orsucci, Lorella
    Morra, Enrica
    Gaidano, Gianluca
    Cairoli, Roberto
    [J]. BLOOD, 2015, 126 (23)
  • [10] Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia.
    Treon, SP
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Kimby, E
    Lister, A
    Morel, P
    Kelliher, A
    Branagan, A
    Preffer, F
    Anderson, KC
    [J]. BLOOD, 2002, 100 (11) : 211A - 211A
12345